Navigation Links
Bugged about super bugs

Winnipeg – Super-bugs are growing in numbers in Canadian hospitals, way beyond estimation, raising concern among health experts.//

George Zhanel, primary investigator in the study said, “The stark reality in this country today is that MRSA (methicillin-resistant staphylococcus aureus) and other drug-resistant bacteria are posing a serious threat in our ICUs (intensive care units). People infected with these super bugs are more likely to have longer hospital stays and require multiple drug treatments to fight them off and even then, it's often too little, too late.”

The study investigated nearly 4,000 samples taken from 19 intensive care units in Canadian hospitals. The examination revealed that 20 to 50 percent of staphylococcus aureus bacteria, which is a major cause of wound and skin infections, was not responding to the antibiotic methicillin.

Research has indicated that if antibiotics are used at the appropriate time, they prove to be effective against a variety of super bugs. Treatment measures can resort to broad-spectrum antibiotics till such time the key bacteria is identified, the researchers opined. The study also indicated, though most super bug infections are contracted in hospitals, yet the infection is also found in athletes, soldiers and intravenous drug users who suffer treatment-resistant skin infections and pneumonia.


SV
'"/>




Page: 1

Related medicine news :

1. More about HIV
2. Teens listen to parents about smoking
3. Spreading knowledge to doctors about herbal medicine
4. A new discovery about Acetaminophen
5. A new discovery about Acetaminophen
6. An insight about Schizophrenia
7. FDA to bring about changes in Marketed Non-Steroidal Anti-Inflammatory Drugs
8. Study shows that interventions from health workers can bring about changes in asthma causes
9. People suffering from Alzheimer’s: can they take decisions about their treatment
10. New info about Huntingtons disease found
11. New clues about immune system from leprosy microbes
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2017)... ... 28, 2017 , ... Semrock’s highly popular SearchLight Spectra Viewer ... resource for fluorescence microscopists and optical system designers, enabling The Right Solution, Right ... the globe, SearchLight has become a tremendously popular tool for the fluorescence imaging ...
(Date:4/27/2017)... ... April 27, 2017 , ... Thinksport, the leaders in safe, ... award-winning sunscreen they’ve used the same scientific approach to solving smelly, sweaty athletes, ... the aisles that contain harmful chemicals that should be put nowhere near your ...
(Date:4/27/2017)... ... April 27, 2017 , ... Offering the purest product of its ... times purer and more potent than the market has seen before. Swissx uses proprietary ... well as a patented chromatography process for extraction, to produce its CBD oil--maximizing its ...
(Date:4/26/2017)... , ... April 26, 2017 , ... Journal of ... It can have severe consequences to overall dental health, including complications with speech, eating, ... turn to dental implants to replace lost teeth. As the number of tooth replacements ...
(Date:4/26/2017)... ... April 26, 2017 , ... The ... Excellence upon National Registry of Emergency Medical Technicians and welcomes this ... said Dr. Jan G. West, Ph.D. , CEO & Organizational Psychologist at ...
Breaking Medicine News(10 mins):
(Date:4/24/2017)... England , April 24, 2017 ... development, today announced the addition of a major ... ,Validated In-situ Plate Seeding,). The VIPS has been ... and 384 well microplates as part of the ... system offers a simple and more reliable solution ...
(Date:4/20/2017)... 2017 Research and Markets has ... and Market Prospects: Addressing Production Complexities Through Risk Management ... ... Biosimilar Pipeline and Market Prospects: Overcoming Production Complexities Through ... assessment of the current trends in the global biosimilars ...
(Date:4/20/2017)... -- AbbVie (NYSE: ABBV), a global biopharmaceutical company, today ... C virus (HCV) infected patients with genotype 1, ... (Child-Pugh A) achieved sustained virologic response at 12 ... pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high SVR ... of G/P treatment without ribavirin. Patients with specific ...
Breaking Medicine Technology: